USANA Health Sciences (NYSE:USNA) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday, Zacks.com reports.
According to Zacks, “USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company’s three primary product lines consist of nutritional, personal care and weight management products. The company’s products are distributed primarily through a network marketing system. “
USANA Health Sciences stock traded down $0.87 during trading hours on Tuesday, hitting $88.05. The company had a trading volume of 88,133 shares, compared to its average volume of 89,740. The firm has a market cap of $1.76 billion, a P/E ratio of 13.28 and a beta of 0.85. USANA Health Sciences has a 1 year low of $72.03 and a 1 year high of $107.85. The company has a 50-day moving average price of $96.53 and a two-hundred day moving average price of $98.84.
In other USANA Health Sciences news, insider Robert A. Sinnott sold 1,648 shares of the company’s stock in a transaction that occurred on Monday, August 16th. The shares were sold at an average price of $95.04, for a total transaction of $156,625.92. Following the transaction, the insider now owns 1,648 shares in the company, valued at approximately $156,625.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Frederic J. Winssinger sold 926 shares of the company’s stock in a transaction that occurred on Thursday, July 29th. The shares were sold at an average price of $99.08, for a total transaction of $91,748.08. Following the transaction, the director now owns 2,516 shares in the company, valued at approximately $249,285.28. The disclosure for this sale can be found here. In the last 90 days, insiders sold 3,435 shares of company stock valued at $331,837. Company insiders own 0.21% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in the company. State Board of Administration of Florida Retirement System boosted its holdings in shares of USANA Health Sciences by 3.6% in the 1st quarter. State Board of Administration of Florida Retirement System now owns 4,314 shares of the company’s stock valued at $421,000 after acquiring an additional 150 shares during the last quarter. ProShare Advisors LLC boosted its holdings in shares of USANA Health Sciences by 4.9% in the 2nd quarter. ProShare Advisors LLC now owns 3,609 shares of the company’s stock valued at $370,000 after acquiring an additional 167 shares during the last quarter. UBS Asset Management Americas Inc. boosted its holdings in USANA Health Sciences by 2.9% during the second quarter. UBS Asset Management Americas Inc. now owns 10,267 shares of the company’s stock worth $1,052,000 after buying an additional 285 shares in the last quarter. Point72 Hong Kong Ltd purchased a new stake in USANA Health Sciences during the first quarter worth $29,000. Finally, Altshuler Shaham Ltd purchased a new stake in USANA Health Sciences during the first quarter worth $37,000. 54.77% of the stock is currently owned by institutional investors and hedge funds.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures nutritional, personal care and weight-management products. Its product line divided into four categories: Essentials, Optimizers, Foods, Personal Care and Skincare, and All Other. The Essentials Nutritionals category includes vitamin and mineral supplements that provide a foundation of advanced total body nutrition for every age group.
Read More: What is the Stochastic Momentum Index (SMI)?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.